Stock Earnings

Question 1

Quels sont les états financiers clés de United Therapeutics Corp ?

Accepted Answer

Selon le dernier état financier (Form-10K), United Therapeutics Corp a un total d'actifs de $7,364, un bénéfice net profit de $1,195

Question 2

Quels sont les ratios financiers clés pour UTHR ?

Accepted Answer

Le ratio de liquidité de United Therapeutics Corp est 8, la marge nette est 41.53, les ventes par action sont de $59.31.

Question 3

Comment les revenus de United Therapeutics Corp sont-ils répartis par segment ou géographie ?

Accepted Answer

United Therapeutics Corp largest revenue segment is Other, at a revenue of 22,100,000 in the most earnings release.For geography, United States is the primary market for United Therapeutics Corp, at a revenue of 2,739,700,000.

Question 4

United Therapeutics Corp est-elle rentable ?

Accepted Answer

yes, selon les derniers états financiers, United Therapeutics Corp a un bénéfice net profit de $1,195

Question 5

United Therapeutics Corp a-t-elle des passifs ?

Accepted Answer

yes, United Therapeutics Corp a un passif de 920

Question 6

Combien d'actions en circulation United Therapeutics Corp a-t-elle ?

Accepted Answer

United Therapeutics Corp a un total d'actions en circulation de 44.83

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	3,128	2,877	2,327	1,936	1,685	1,483
Revenue Growth (YoY)	14%	24%	20%	15%	14%	2%
Cost of Revenue	356	309	257	151	122	108
Gross Profit	2,771	2,567	2,070	1,784	1,563	1,375
Selling, General & Admin	705	638	473	470	464	423
Research & Development	544	481	408	322	410	357
Operating Expenses	1,249	1,119	881	793	874	781
Other Non Operating Income (Expenses)	8	14	1	-4	-8	104
Pretax Income	1,666	1,539	1,274	950	593	638
Income Tax Expense	394	343	289	223	118	124
Net Income	1,271	1,195	984	727	475	514
Net Income Growth	15%	21%	35%	53%	-8%	-594%
Shares Outstanding (Diluted)	47.3	48.5	49.7	48.5	47.3	44.6
Shares Change (YoY)	-2%	-2%	2%	3%	6%	2%
EPS (Diluted)	26.88	24.64	19.81	15	10.06	11.54
EPS Growth	17%	24%	32%	49%	-13%	-583%
Free Cash Flow	1,116	1,080	747	663	477	696
Free Cash Flow Per Share	23.59	22.26	15.03	13.67	10.08	15.6
Gross Margin	88.58%	89.22%	88.95%	92.14%	92.75%	92.71%
Operating Margin	48.65%	50.33%	51.05%	51.13%	40.83%	39.98%
Profit Margin	40.63%	41.53%	42.28%	37.55%	28.18%	34.65%
Free Cash Flow Margin	35.67%	37.53%	32.1%	34.24%	28.3%	46.93%
EBITDA	1,604	1,520	1,241	1,041	737	642
EBITDA Margin	51.27%	52.83%	53.33%	53.77%	43.73%	43.29%
D&A For EBITDA	82	72	53	51	49	49
EBIT	1,522	1,448	1,188	990	688	593
EBIT Margin	48.65%	50.33%	51.05%	51.13%	40.83%	39.98%
Effective Tax Rate	23.64%	22.28%	22.68%	23.47%	19.89%	19.43%

United Therapeutics Corp (UTHR) Price

UTHR Stock Price Chart

UTHR Income

Follow-Up Questions